Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256490
Status:
UNKNOWN
Last Update Posted:
2005-11-21
First Post:
2005-11-17
Brief Title:
Early Evaluation of the Response of Large B Cell Non Hodgkins Lymphoma to Chemotherapy by PETCT
Sponsor:
Université de Sherbrooke
Organization:
Université de Sherbrooke
Study Overview
Official Title:
Early Evaluation of the Response of Large B Cell Non Hodgkins Lymphoma to Chemotherapy by Positron Emission Tomography Coupled With Computed Tomography PETCT
Status:
UNKNOWN
Status Verified Date:
2005-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients affected with non-Hodgkins large B-cell lymphoma are treated by chemotherapy The evaluation of the response to this treatment is made by Positron Emission Tomography PETCT in many centres where this technology is available Presently PET scans and CT scans are being performed before treatment after 4 cycles of chemotherapy and a few months after the end of treatment
The goal of this study is to determine if it is possible to evaluate the efficiency of chemotherapy treatments after one cycle of treatment instead of waiting after 4 cycles using a new scanner that combines PET and CT modalities Data available from studies on these combined exams suggest that PETCT helps to rapidly evaluate the response of the chemotherapy treatment We also want to verify if some pathological characteristics measured from tumor cells will enable doctors to predict in advance the response to treatment
The goal of this study is to determine if it is possible to evaluate the efficiency of chemotherapy treatments after one cycle of treatment instead of waiting after 4 cycles using a new scanner that combines PET and CT modalities Data available from studies on these combined exams suggest that PETCT helps to rapidly evaluate the response of the chemotherapy treatment We also want to verify if some pathological characteristics measured from tumor cells will enable doctors to predict in advance the response to treatment
Detailed Description:
Participation in this study involves 4 PETCT exams which occur before the treatments start after the first cycle of chemotherapy after 4 cycles of chemotherapy and then 12 weeks after the end of the treatments The only additional test performed in this study compared to the regular follow-up of patients that are not in this study is the PETCT exam after the first cycle Your participation in this study will not affect treatment since the results of the first PETCT test will not be communicated All other tests results will be available in the medical record
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CIMF 2005-01 | None | None | None |